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Abstract
Background: Returning to and staying at work following illness is associated with better physical and psychological functioning.
Not working has been shown to be associated with reduced self-esteem, lowered self-efficacy, and decreased belief in one's ability
to return to the workplace. Although there is a growing body of research looking at what predicts return to work following cancer
treatment, there are fewer studies examining interventions targeting return to work.
Objective: The primary objective is to assess the feasibility and acceptability of a theoretically led workbook intervention
designed to support cancer patients in returning to work to inform a fully powered randomized controlled trial (RCT).
Methods: This is a multicenter feasibility RCT where the main analysis uses a qualitative approach. Sixty participants (aged
18-65 years) who have received a diagnosis of cancer and who intend to return to work will be randomized to either the WorkPlan
intervention group or a usual care group (ratio 1:1). Participants in the intervention group will receive a guided workbook
intervention (which contains activities aimed at eliciting thoughts and beliefs, identifying targets and actions, and concrete steps
to achieve goals) and will receive telephone support over a 4-week period. The primary outcome measure is time taken to return
to work (in days), and secondary outcome measures include mood, quality of life, illness perceptions, and job satisfaction. Data
will be collected through postal questionnaires administered immediately postintervention and at 6- and 12-month follow-ups.
In addition, interviews will be undertaken immediately postintervention (to explore acceptability of the intervention and materials)
and at 12-month follow-up (to explore perceptions of participation in the trial and experiences of returning to work).
Results: Enrollment for the study will be completed in May 2016. Data analysis will commence in April 2017, and the first
results are expected to be submitted for publication in late 2017.
Conclusions: Currently no standardized return-to-work intervention based on targeting cancer patient beliefs is in existence. If
the intervention is shown to be feasible and acceptable, the results of this study will inform a future full RCT with the potential
to provide a valuable and cost-efficient tool in supporting cancer survivors in the return-to-work process.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): ISRCTN56342476;
http://www.isrctn.com/ISRCTN56342476 (Archived by WebCite at http://www.webcitation.org/6gblhEPXd).
(JMIR Res Protoc 2016;5(2):e75)   doi:10.2196/resprot.5300
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Introduction
Overview
Returning to and staying in work following illness is associated
with better physical and psychological functioning. Not working
has been shown to be associated with reduced self-esteem,
lowered self-efficacy, and decreased belief in one's ability to
return to the workplace [1]. Employment is important not only
for individual and societal economic reasons [2] but because
being out of work is thought to cause, contribute to, and
aggravate adverse health outcomes [3,4]. Furthermore, work is
an important component of quality of life [5]. The relationship
between unemployment and negative health outcomes is thought
to be mediated by factors such as socioeconomic status, financial
anxiety, and a stress pathway involving physical changes
including hypertension and lowered immunity [6,7]. Although
there is a growing body of research looking at what predicts
return to work (most commonly defined as returning to work
quicker and improved self-reported ability to undertake one's
role, or workability) following cancer treatment, there are fewer
studies examining interventions targeting return to work.
Over 100,000 people of working age receive a diagnosis of
cancer each year in the United Kingdom [8]. Earlier diagnosis
and improvements in treatment survival rates have led to an
increase in the number of cancer survivors. UK policy reviews
have highlighted a need for more research into the challenges
of living with cancer [9,10]. For many cancer survivors returning
to work is a realistic outcome. Many patients do well following
treatment; however, some experience ongoing negative
outcomes from the disease or treatment (including pain, fatigue,
and low mood) that may impact everyday functioning, including
work [11]. Over a quarter of cancer survivors report high
symptom burden one year post-diagnosis, even after treatment
termination [12]. In addition, many cancer survivors still
undergo some form of treatment/monitoring for substantial
periods of time following termination of active treatment. Return
to work rates of between 23% and 75% have been reported [13],
and cancer patients are 1.4 times more likely to be unemployed
than healthy individuals [4]. Furthermore, return-to-work rates
have been shown to vary across cancer types [14], and longer
return to work times have been reported among patients
undergoing certain treatments (surgery/chemotherapy) [15],
experiencing fatigue [16], or reporting a nonsupportive work
environment [17]. Although some cancer types have a high
return-to-work rate, we know that across cancer types we see a
significant proportion of patients return to work too early or in
an inappropriate manner, which results in them taking additional
sick leave or leaving the workplace [16]. In addition, a large
proportion of cancer patients report modifications in working
hours, wages, and work patterns as well as reporting perceived
reductions in workability [13]. Cancer survivors have been
shown to have similar work-disability levels to those reported
in other chronic conditions (eg, stroke, diabetes, heart disease,
arthritis) but significantly higher work-disability levels when
compared with age-matched adults with no reported chronic
condition [18]. This supports the finding that cancer survivors
often report difficulties in achieving productivity levels similar
to healthy counterparts [19].
Predictors of longer time to return to work include a range of
disease and treatment, work-related and psychological factors
[20]. The relative role of each of these factors is difficult to
determine because few studies directly compare these factors
or they focus on either a single cancer type or a mixed-cancer
sample. However, a recent study [14] examined these factors
across four distinct cancer types and identified that, in addition
to optimal symptom management and appropriate workplace
adaptations, specific cancer (ie, beliefs about the consequences
of cancer) and treatment-related (ie, beliefs about controlling
the effects of cancer at work) perceptions predicted return to
work.
Cancer patients have reported apprehensions about returning to
work related to concerns about ongoing treatments and their
level of physical fitness [21]. In addition, depressive symptoms
are associated with reduced return-to-work rates, and partial or
full resumption of work may help alleviate depressive symptoms
by challenging dysfunctional beliefs [22]. Research from
noncancer disease groups also supports the importance of
psychological factors in the return to work process. Among
patients diagnosed with coronary heart disease, depression has
been shown to impact functional recovery and predict failure
or delay in returning to work [23,24]. Perceptions of illness
[25,26,27] and work-related disability (independent of physician
report of disability) [28] are also predictive of reemployment
and occupational functioning.
In the field of cancer, a number of intervention and trial
protocols have been published. Such interventions include a
12-week occupational physician-led intervention focused on
increasing physical activity in cancer survivors to support return
to work [29]; a case management approach focusing on
signposting/referring patients to services (eg, physiotherapy and
occupational or psychological therapy) that may support return
to work [30]; and a tool that cancer survivors use to guide
discussions about working [31]. Although this tool was initially
well received, it focused on guiding questions during interactions
with employers and healthcare professionals and not on beliefs
and barriers that impact workability and work behavior. A recent
Cochrane systematic review identified the need for more
high-quality randomized controlled trials (RCTs) to enhance
return to work among cancer patients [32]. Last, a recent
metasynthesis of qualitative research studies highlighted the
need for vocational interventions with cancer patients to be
person-centred and for such interventions to acknowledge the
role of social, clinical, and work-related factors [33].
Current Study
Feasibility studies are conducted before a main study and are
used to estimate key parameters to support the design of a full
RCT [34]. This feasibility randomized controlled study will
trial and evaluate the WorkPlan guided workbook intervention,
a theoretically led intervention aimed at targeting known
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psychological factors to improve work-related outcomes among
cancer survivors. The primary objective of the study is to trial
the workbook intervention and data collection materials to
ensure that the materials are acceptable to participants and that
participants are able to provide full answers. This objective will
be met through five aims.
In aim 1, data collection materials will be trialed to ensure that
the materials are acceptable to participants. We will identify
whether the materials are acceptable to participants and whether
participants understand and are able to complete the required
tasks.
In aim 2, the recruitment process and feasibility of recruiting
participants into the study will be tested. We will observe
whether we are able to meet the required monthly recruitment
targets, identify which methods of recruitment are most
successful in attracting participants into the study, and determine
if changes could be made to future studies to improve
recruitment.
In aim 3, we will test the acceptability of the randomization
process among participants. As part of the final interview
process we will discuss the randomization process with
participants to determine the level of understanding and
satisfaction with the information provided.
In aim 4, we will determine retention in control and intervention
groups to the 12-month follow-up. Where possible we will
determine reasons for attrition in both arms.
In aim 5, we will conduct the groundwork necessary to obtain
data that will be required in the definitive trial to enable a full
cost-effectiveness analysis. Measures to be used in a full trial
will be administered for acceptability.
The study is registered with the UK Clinical Research Network
(UKCRN ID: 19013) and the International Standard Randomized
Controlled Trial Number registry [ISRCTN: 56342476]. The
protocol version is 4.1, date 11.11.2015. The recruitment status
is open (participants are currently being recruited and enrolled
into the study).
Methods
Eligibility Criteria
Inclusion criteria: patients who have received a diagnosis of
breast, gynecological, urological, or bowel cancer that has not
been classified as metastatic disease or recurrence; are at least
2 weeks posttreatment initiation; are aged 18 to 65 years; were
working at the time of diagnosis; and are not currently working
but intend to return to work.
Participants will be recruited to the study from multiple UK
hospital sites. We aim to recruit 60 participants who will be
randomized into either the intervention or the usual care group.
There are currently no clear guidelines for estimating an
appropriate sample size for feasibility studies. This is not a
hypothesis testing study; the sample size is based on pragmatic
assumptions around feasible recruitment figures and the number
of participants required to estimate the key parameters around
the feasibility of a full RCT.
WorkPlan Intervention
The WorkPlan package is theoretically led and based around
the self-regulation model [35] and goal setting theory [36],
which have been applied previously in return-to-work
interventions. WorkPlan was developed around an intervention
mapping methodology used for designing and implementing
complex interventions or programs (interventions that comprise
a number of separate elements essential to the functioning of
the intervention as a whole). WorkPlan is delivered as a 4-week
guided workbook intervention consisting of structured sections
and activities to provide guidance and support to patients. The
workbook is broken down into 4 chapters that participants are
encouraged to work through in turn during each week of the
intervention period. The workbook comprises activities aimed
at eliciting thoughts/beliefs, identifying targets/actions, and
adopting concrete steps to achieve goals. Participants incorporate
all elements from the workbook into a personal “return-to-work”
plan which they are encouraged to create in the fourth and final
week. A resources section is included to signpost participants
toward relevant avenues of further support. Multiple copies of
the return-to-work planning page will be available to encourage
changes to be made when necessary, and these plans can be
used as a tool when meeting with employers to aid discussion
around returning to work. An intervention manual has also been
developed to be used by the researchers during the delivery of
the intervention.
Intervention Group
Patients in the intervention group will be guided through the
initial exercises and given a detailed overview of the workbook.
They will be encouraged to discuss the workbook with their
partner, family, or friends. Telephone support calls will be made
by the researchers at 2 and 4 weeks during the intervention
period to discuss progress. The workbook is used during the
introductory session, at home during the intervention period,
and as a reminder during the return to work process.
Usual Care Group
Participants will receive usual care which focuses on clinical
care and optimal symptom management and will be offered the
workbook at the end of the study. In order to prevent participants
from undertaking activities in the workbook, the following
precautions have been included in the design: (1) the information
sheets and prerandomization discussion do not include the
content or focus of the intervention and (2) the workbook will
not be made available until the participant’s 12-month follow-up.
Participants in either group may access other information and
support relating to work posttreatment but will be asked to
record any resources or information they receive or access
during the trial.
Procedure
Participants will be recruited when they are at least 2 weeks
posttreatment initiation (Figure 1). Patients will be identified
through breast, gynecological, colorectal, or urological cancer
clinics; through multidisciplinary team meetings; and by placing
posters in clinics, chemotherapy suites, and computerized
tomography scan waiting areas. Clinicians will have leaflets
and information packs outlining the study and providing contact
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details available for patients. Study materials have been
translated into the five most commonly spoken languages among
people of working age in Birmingham (2011 Census): Bengali,
Chinese (standard), Polish, Punjabi, and Urdu. Interpreters will
be provided if required.
Potential participants will be provided with contact details and
asked to contact one of the researchers by telephone or email.
Details for the project website will also be displayed on the
leaflets and posters, where potential participants can access
further information about the study. Patients who express interest
in the study will be provided with an information sheet and
eligibility screening questionnaire. Eligible participants will be
sent an invitation to be interviewed at the hospital or over the
telephone; a researcher will outline the study and randomization
process, explain the patient information sheet, and obtain written
consent (if explained via telephone, researchers will obtain
verbal consent after explaining the study and will ask
participants to return a written consent form by postal mail). If
participants provide additional consent, the researchers will
inform their general practitioner about participation in the study.
Participants will receive £20 when they complete the assessment
interview to cover time and travel expenses.
Figure 1. Study flowchart showing allocation to groups.
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Allocation and Stratification
The researchers will randomize participants into one of the two
arms using a central online and text system, Sealed Envelope
(Sealed Envelope Ltd), at a ratio of 1:1 between the intervention
group and usual care group. During the randomization process,
participants will be stratified by age (18-50 or 51-65 years) and
cancer type (breast, bowel, gynecological, or urological).
Patients with different cancer diagnoses may have specific
impairments or side effects due to the location of the cancer or
the treatments received. Hence, stratifying for cancer type
balances out any effects that might be due to this variable.
Treatments undertaken during the follow-up period will be
monitored in both arms of the trial. Participants are informed
about their group allocation (guided intervention or usual care),
and participants allocated to the usual care group will be
informed that they will be offered the workbook after the
12-month follow-up.
Blinding
The researchers will be aware of group allocation at
randomization and during follow-up in order to provide
telephone support to participants in the intervention group.
However, the principal investigator will be blind to participant
group allocation to reduce bias when analyzing data.
Data Collection
Study Outcomes
The main outcome measures of a full RCT will be used (eg,
number of days to return to work and satisfaction with the
return-to-work process). At each time point, participants will
be asked to recall the date of return to work (paid or unpaid
employment, different job, reduced hours/salary, full-time or
part-time). Any changes in working status and duties will be
documented as will specific reasons for nonreturn to work (eg,
unavailability of job, ongoing medical concerns) to determine
whether to incorporate specific reasons for nonreturn as
measures in a full trial. Secondary outcome measures include
mood, satisfaction with return to work, and satisfaction with
the return-to-work process. Although not appropriate for a
feasibility trial, we would aim to undertake subgroup analysis
of the primary outcome measure by cancer type/site in a future
definitive RCT.
Data will be collected at 4 time points during the study: baseline,
4 weeks (postintervention), and 6- and 12-month follow-ups.
At each time point participants will complete the following
questionnaires:
• Illness Perceptions Questionnaire-Revised [37]
• Brief Illness Perception at Work Scale [38]
• Hospital Anxiety and Depression Scale [39]
• Work Ability Index [40]
• Satisfaction with return to work if returned to work (single
item)
• Satisfaction with Work Scale [41] (if returned to work)
• EQ-5D-5L (Quality of Life) [42]
• Visual Analogue Scale measure of Quality of Life (single
item) [43]
Questionnaire packs will be mailed to participants with a prepaid
self-addressed envelope. In addition, participants will be asked
to provide details of their use of services and information via
text message. A maximum of 4 text messages will be sent to
participants at the end of each month for the duration of the
study to gather information on their current work status and
healthcare utilization. Monthly intervals were chosen because
research shows that memory of general practitioner
appointments is around 4 weeks, so we could not rely on
accurate recall of healthcare utilization at 6-month follow-ups
[44,45]. The text-based service can also be used for reminders
to participants to complete and return questionnaire packs if
there is missing data.
Interviews
Twenty participants from the intervention group will be
interviewed postintervention and 12 months postrandomization,
and 20 participants from the usual care group will be interviewed
12 months postrandomization. Participants will be asked to
participate sequentially until the recruitment target is reached.
Interviews will be conducted over the telephone or face to face,
depending on the participant's preference. The postintervention
interview will focus on gaining perceptions of (1) how the
intervention was delivered; (2) aspects of the intervention
individuals found useful; and (3) compliance with the
intervention, how aspects of the intervention were used, and
recommendations for change. The 12-month interview will
explore (1) experiences of the randomization process, (2) general
perceptions of the trial, and (3) the personal return-to-work
process of each individual. Members of both groups will be
asked about their experiences and how this may have impacted
their return to work as well as any additional support received
regarding return to work.
Data Management
To maintain confidentiality, all participants will be given a
unique identifier that will be used on all hard copy and database
records. Patient names will not be used. Clinical and research
government guidelines will be followed for safe and confidential
storage of participant personal data (such as password-protected
data files), to which only the research team directly involved in
the study will have access. If a participant withdraws from the
study, identifiable data which has already been collected with
consent would be retained and used in the study, but no further
data would be collected from the participant.
Analysis Plan
Qualitative Analysis
Although this is a mixed-methods study, the main focus of the
analysis of the study will be qualitative. Interviews will be
recorded, transcribed verbatim, and analyzed using the
framework method [46] to identify emergent themes.
Quantitative Analysis
The purpose of this feasibility study is not hypothesis testing.
Furthermore, it is anticipated that the sample size will be
underpowered to undertake the full analysis that would be used
in a full trial (analysis of covariance adjusting for baseline
values). Baseline characteristics will be reported as mean and
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standard deviations or medians and interquartile ranges for
continuous data and as n (%) for categorical data. Differences
between the intervention and control groups for the primary
outcome measure will be examined. Secondary outcome
measures will be assessed using independent samples t tests
(significance level set at .05).
Economic Analysis
Although an economic evaluation is not suitable in the context
of a feasibility trial, we will undertake a descriptive economic
analysis focusing on the resource usage of the intervention
(intervention materials, time, follow-ups/support), self-reported
indirect costs including paid sick days/unemployment benefits,
and healthcare utilization. The EQ-5D-5L will be used to inform
the changes in quality of life over time, and these can contribute
to the calculation of quality-adjusted life years in a full economic
evaluation.
Data Monitoring
This is a feasibility trial, so a data monitoring committee will
not be convened. However, the project steering committee will
review safety and efficacy data throughout the trial. Personal
data will be accessed by the research team only and will be
stored for 12 months after the study has ended and then moved
to a secure archiving facility for 5 years.
Ethics
Ethical approval for this study has been obtained from West
Midlands–Solihull (National Research Ethics Service) Research
Ethics Committee (Reference: 15/WM/0166). The principal
investigator will communicate any amendments to protocol to
members of the research team, who will inform trial participants
by postal mail if relevant.
Harms
Because the trial focuses on a workbook-based intervention
aimed at promoting return to work, we do not envisage any
adverse events or a need to stop the trial prematurely. It is
unlikely that the intervention would cause distress, although
participants may experience distress while discussing their work
in the context of having experienced cancer. Procedures will be
in place for participants to access psychological support services
if required.
Dissemination Policy
Results from the study will be reported and disseminated through
publication in peer-reviewed scientific journals and presentations
at relevant conferences. A lay summary of the findings of the
study will be mailed or emailed to the participants if they express
interest.
Results
The project was funded in March 2015, and enrollment will be
completed in May 2016. Data analysis will commence in April
2017, and the first results are expected to be submitted for
publication in late 2017.
Discussion
Principle Considerations
There is currently no available standardized return-to-work
intervention focused on targeting cancer patient beliefs. Previous
research [47,48] has demonstrated that both cancer patients and
organizations report that such an intervention would be
invaluable to facilitate return to work and ensure work retention.
Undertaking a feasibility study is critical to inform the planning
of a larger, fully powered RCT to improve work-related
outcomes among cancer survivors. The results of the study will
be used to modify the trial materials and methodology if required
and determine likely recruitment and retention rates for a larger
trial. If appropriate, the results of the feasibility study will be
used to estimate a sample size calculation for a future
(appropriately powered) RCT of the intervention with a longer
follow-up period. If a fully powered RCT were to demonstrate
that the WorkPlan intervention is more effective in supporting
return to work than usual care, this would allow us to implement
a valuable, cost-efficient tool to support people who have
received a diagnosis of cancer in planning and achieving
supported return to work as well as greater satisfaction with
work and the return-to-work process.
Methodological Considerations
One strength of this study is that it uses a theoretically based
intervention. The study follows the best practice guidelines set
out by the Medical Research Council, the UK national funding
agency, in the development and evaluation of complex
interventions [49] and published recommendations for pilot
studies [50-53]. The intervention package was developed in
several stages. A review of the literature identified that few
studies focusing on return to work had targeted participant
beliefs and yet the role of beliefs in the performance of
numerous behaviors, including return to work, has previously
been documented [54,55]. A prospective questionnaire study
was developed and administered to identify which clinical,
work-related, and psychological variables influence the
return-to-work process among cancer patients. As part of this
study, qualitative interviews were undertaken to gain further
information about the patients’ vocational aspirations,
perceptions of the process of returning to work, and beliefs
regarding their ability to return to work. The study demonstrated
the role played by illness perceptions and beliefs about the
impact of illness on return to work as well as differences in
predictive factors across cancer types [14,56,57]. The results
of this research were used to map the intervention components
through an intervention mapping methodology used for
designing and implementing complex interventions or programs.
It has been used for over 20 years for systematically designing
multifaceted programs involving numerous interventions
directed at various individuals and environments [58]. This
methodology is suited to the development of a return-to-work
program because it is a complex intervention requiring a tailored
and multifaceted approach. Further strengths of the study:
chosen self-reported outcome measures relate directly to the
components addressed through the intervention, resources are
available to support a diverse sample within the study, and a
qualitative analysis approach will be used. Qualitative methods
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are increasingly applied in the developmental stages of RCTs
of complex interventions [58]. Qualitative methods are often
used to evaluate participants’ understanding and experience of
an intervention. Individual in-depth interviews allow exploration
of why some participants may respond more positively to the
intervention and what modifications may be required to suit
different groups of participants (eg, differences between cancer
types and occupation types, specific gender-based needs).
Conclusion
This feasibility study may be the first step in the development
of an intervention that provides long-term benefits and may
have some immediate benefits for the sample who participate.
The intervention will provide cancer survivors with the skills
and confidence to manage their return to work. The intervention
may improve long-term job retention among cancer survivors
with the potential to be adapted for other conditions.
Furthermore, the intervention may have long-term implications
for improving psychological outcomes among cancer survivors
through improvements in well-being, mood, and physical
functioning, all of which could impact the utilization of national
health services.
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